BOSTON, Feb. 11 (UPI) -- Researchers reported Tuesday on promising new drugs that attack -- in new ways -- the virus that causes AIDS. At a major AIDS conference in Boston doctors said the pharmaceutical pipeline is filling up with robust answers to the ability of the human immunodeficiency virus to mutate and defeat therapy.
Since 1907, United Press International (UPI) has been a leading provider of critical information to media outlets, businesses, governments and researchers worldwide. UPI is a global operation with offices in Beirut, Hong Kong, London, Santiago, Seoul and Tokyo. Our headquarters is located in downtown Washington, DC, surrounded by major international policy-making governmental and non-governmental organizations.
UPI licenses content directly to print outlets, online media and institutions of all types. In addition, UPI's distribution partners provide our content to thousands of businesses, policy groups and academic institutions worldwide. Our audience consists of millions of decision-makers who depend on UPI's insightful and analytical stories to make better business or policy decisions.
In the year of our 106th anniversary, our company strives to continue being a leading and trusted source for news, analysis and insight for readers around the world.